Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel anticancers and dermatological adversities: old rivals but new challenges.

× No keyword cloud information.

7 in total

1. Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reaction.

Authors: Kei Kunimasa; Taiki Isei; Harumi Nakamura; Madoka Kimura; Takako Inoue; Motohiro Tamiya; Kazumi Nishino; Toru Kumagai; Shin-Ichi Nakatsuka; Hiroko Endo; Masahiro Inoue; Fumio Imamura
Journal: Invest New Drugs Date: 2018-06-26 Impact factor: 3.850

2. Image Gallery: Flagellate dermatitis.

Authors: G U Sawatkar; K K Sahu; G Prakash; S Dogra
Journal: Br J Dermatol Date: 2016-04 Impact factor: 9.302

3. Bullae And Blisters: A Rare Case of Bendamustine Skin Toxicity.

Authors: Kamal Kant Sahu; Gitesh Upendra Sawatkar; Preethi Jeyaraman; Gaurav Prakash; Subhash C Varma; Pankaj Malhotra
Journal: Indian J Hematol Blood Transfus Date: 2016-02-04 Impact factor: 0.900

4. Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.

Authors: Martina Sanlorenzo; Igor Vujic; Adil Daud; Alain Algazi; Matthew Gubens; Sara Alcántara Luna; Kevin Lin; Pietro Quaglino; Klemens Rappersberger; Susana Ortiz-Urda
Journal: JAMA Dermatol Date: 2015-11 Impact factor: 10.282

5. Revisiting cutaneous adverse reactions to pemetrexed.

Authors: Claudine Piérard-Franchimont; Pascale Quatresooz; Marie-Annick Reginster; Gérald E Piérard
Journal: Oncol Lett Date: 2011-07-05 Impact factor: 2.967

6. Debilitating Skin Toxicity Associated with Pembrolizumab Therapy in an 81-Year-Old Female with Malignant Melanoma.

Authors: Muhammad O Khokhar; Jacob Kettle; Amruth R Palla
Journal: Case Rep Oncol Date: 2016-12-08

7. Mandatory dexamethasone strictly monitored by pharmacists reduces the severity of pemetrexed-induced skin rash.

Authors: Naoko Usui; Yoko Kondo; Noriko Ryota; Hidekazu Suzuki; Norio Okamoto; Masumi Sando; Eriko Tani; Masanari Hamaguchi; Ayako Tanaka; Motohiro Tamiya; Takayuki Shiroyama; Naoko Morishita; Emiko Tanaka; Tomonori Hirashima
Journal: Eur J Hosp Pharm Date: 2016-08-03

7 in total

5 in total

Novel anticancers and dermatological adversities: old rivals but new challenges.

1. Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reaction.

2. Image Gallery: Flagellate dermatitis.

3. Bullae And Blisters: A Rare Case of Bendamustine Skin Toxicity.

4. Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.

5. Revisiting cutaneous adverse reactions to pemetrexed.

6. Debilitating Skin Toxicity Associated with Pembrolizumab Therapy in an 81-Year-Old Female with Malignant Melanoma.

7. Mandatory dexamethasone strictly monitored by pharmacists reduces the severity of pemetrexed-induced skin rash.

1. Rare Presentations of Acute Lymphoblastic Leukemia.

2. Acute generalised skin rash secondary to the Nystatin Oral Suspension.

3. Role of immunotherapy in metastatic renal cell cancer: past, present and future.

4. Contralateral internal iliac artery transposition for retroperitoneal sarcoma involving common iliac artery.

5. To study the contributing factors and outcomes of Clostridioides difficile infection in patients with solid tumors.